The Effects of Focal Vibration on Spasticity in Multiple Sclerosis Pat
The Effects of Focal Vibration on Central and Peripheral Spasticity in Multiple Sclerosis Patients. A Randomized, Multicenter, Double Blinded vs Placebo Study
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Equistasi
Placebo
- Placebo
What it measured
Main measures
Gait Velocity
one year
Walking and mobilityFirst step length
one year
Swing phase
one year
Stance phase
one year
Double support time
one year
Other measures (3)
H/M ratio
one year
Nerve conduction testsBerg Balance Scale
one year
Walking and mobilityModified Fatigue Scale
one year
Fatigue
Who could take part
MS (type not specified) · 18 to 65 · EDSS 0 to 5
Show the full criteria
Inclusion criteria
* Multiple Sclerosis affected * Spasticity * EDSS (Expanded Disability Status Scale) 0 - 5,5 * Patients able to sign informed consent
Exclusion criteria
* Age less than 18 years old and more than 65 years old * Pacemaker * Pregnancy * Comorbidities as: cancer, hypertension not controlled by drugs * concurrent therapies with antidepressant or corticosteroids
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This trial consists of application of little devices (named Equistasi®) generating focal vibrations to treat spasticity in neurological patients, affected by multiple sclerosis. The expected effects are on gait and postural instability.
Loading reviews and guidelines…
History
Started
Aug 2016
Main results due
May 2017
Finished
Jul 2017